Thanks to their immune properties, the mesenchymal stem cells (MSC) are a promising source for cell therapy. Current clinical trials show that MSC administrated to patients can treat different diseases (graft-versus-host disease (GVHD), liver cirrhosis, systemic lupus, erythematosus, rheumatoid arthritis, type I diabetes). In this case, the most common mode of cell administration is the intravenous injection, and the hemodynamic environment of cells induced by blood circulation could interfere on their behavior during the migration and homing towards the injured site. After a brief review of the mechanobiology concept, this paper will help in understanding how the mechanical environment could interact with MSC behavior once they are injected to patient in cell-based treatment.
DominiciM.Le BlancK.MuellerI.Slaper-CortenbachI.MariniF.KrauseD.DeansR.KeatingA.ProckopD. and HorwitzE., Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement, Cytotherapy8 (2006), 315–317. doi:10.1080/14653240600855905.
2.
BenvenutoF.FerrariS.GerdoniE.GualandiF.FrassoniF.PistoiaV.MancardiG. and UccelliA., Human mesenchymal stem cells promote survival of T cells in a quiescent state, Stem Cells25 (2007), 1753–1760. doi:10.1634/stemcells.2007-0068.
3.
TisatoV.NareshK.GirdlestoneJ.NavarreteC. and DazziF., Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease, Leukemia21 (2007), 1992–1999. doi:10.1038/sj.leu.2404847.
4.
StoltzJ.F.HuselsteinC. and de IslaN., Influence of mechanical forces on cells and tissues, in: Regenerative Medicine and Cell TherapyStoltzJ.F., ed., Vol. 77, IOS Press BV, Amsterdam, 2012, pp. 111–135.
5.
ZhangY.ChenS. and PeiM., Biomechanical signals guiding stem cell cartilage engineering: From molecular adaption to tissue functionality, Eur Cell Mater31 (2016), 59–78. doi:10.22203/eCM.v031a05.
6.
DanP.VelotE.DecotV. and MenuP., The role of mechanical stimuli in the vascular differentiation of mesenchymal stem cells, J Cell Sci128 (2015), 2415–2422. doi:10.1242/jcs.167783.
7.
SunL.QuL.ZhuR.LiH.XueY.LiuX.FanJ. and FanH., Effects of mechanical stretch on cell proliferation and matrix formation of mesenchymal stem cell and anterior cruciate ligament fibroblast, Stem Cells Int2016 (2016), 9842075. doi:10.1155/2016/6493241.
8.
BecquartP.CruelM.HocT.SudreL.PernelleK.BiziosR.Logeart-AvramoglouD.PetiteH. and BensidhoumM., Human mesenchymal stem cell responses to hydrostatic pressure and shear stress, Eur Cell Mater31 (2016), 160–173. doi:10.22203/eCM.v031a11.
9.
LuoT. and RobinsonD.N., The role of the actin cytoskeleton, in mechanosensitivity and mechanotransduction, in: Mechanosensitivity and MechanotransductionKamkinA. and KiselevaI., eds, Mechanosensitivity in Cells and Tissues Vol. 4, Springer, 2011, pp. 25–65.
10.
UzerG.RubinC.T. and RubinJ., Cell mechanosensitivity is enabled by the LINC nuclear complex, Curr Mol Biol Rep2 (2016), 36–47. doi:10.1007/s40610-016-0032-8.
11.
GuilakF.ButlerD.L.GoldsteinS.A. and BaaijensF.P., Biomechanics and mechanobiology in functional tissue engineering, J Biomech47 (2014), 1933–1940. doi:10.1016/j.jbiomech.2014.04.019.
12.
CapelliC.PedriniO.ValgardsdottirR.Da RoitF.GolayJ. and IntronaM., Clinical grade expansion of MSCs, Immunol Lett168 (2015), 222–227. doi:10.1016/j.imlet.2015.06.006.
13.
KarpJ.M. and Leng TeoG.S., Mesenchymal stem cell homing: The devil is in the details, Cell Stem Cell4 (2009), 206–216. doi:10.1016/j.stem.2009.02.001.
MahmoodA.LuD.LuM. and ChoppM., Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells, Neurosurgery53 (2003), 697–702; discussion 702–693.
16.
SullivanC.BarryF.RitterT.O’FlathartaC.HowardL.ShawG.AnegonI. and MurphyM., Allogeneic murine mesenchymal stem cells: Migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig, Stem Cells Dev22 (2013), 3203–3213. doi:10.1089/scd.2013.0248.
WynnR.F.HartC.A.Corradi-PeriniC.O’NeillL.EvansC.A.WraithJ.E.FairbairnL.J. and BellantuonoI., A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow, Blood104 (2004), 2643–2645. doi:10.1182/blood-2004-02-0526.
19.
KitaoriT.ItoH.SchwarzE.M.TsutsumiR.YoshitomiH.OishiS.NakanoM.FujiiN.NagasawaT. and NakamuraT., Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model, Arthritis Rheum60 (2009), 813–823. doi:10.1002/art.24330.
20.
BoomsmaR.A. and GeenenD.L., Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis, PLoS One7 (2012), e35685. doi:10.1371/journal.pone.0035685.
21.
RingeJ.StrassburgS.NeumannK.EndresM.NotterM.BurmesterG.R.KapsC. and SittingerM., Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2, J Cell Biochem101 (2007), 135–146. doi:10.1002/jcb.21172.
22.
CiprianiP.MarrelliA.BenedettoP.D.LiakouliV.CarubbiF.RuscittiP.AlvaroS.PantanoI.CampeseA.F.GrazioliP.ScrepantiI. and GiacomelliR., Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine, Angiogenesis16 (2013), 595–607. doi:10.1007/s10456-013-9338-9.
23.
SonB.R.Marquez-CurtisL.A.KuciaM.WysoczynskiM.TurnerA.R.RatajczakJ.RatajczakM.Z. and Janowska-WieczorekA., Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases, Stem Cells24 (2006), 1254–1264. doi:10.1634/stemcells.2005-0271.
24.
YuX.ChenD.ZhangY.WuX.HuangZ.ZhouH. and ZhangZ., Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke, Journal of the Neurological Sciences316 (2012), 141–149. doi:10.1016/j.jns.2012.01.001.
25.
MitchellM.J.LinK.S. and KingM.R., Fluid shear stress increases neutrophil activation via platelet-activating factor, Biophys J106 (2014), 2243–2253. doi:10.1016/j.bpj.2014.04.001.
26.
SunddP.PospieszalskaM.K.CheungL.S.KonstantopoulosK. and LeyK., Biomechanics of leukocyte rolling, Biorheology48 (2011), 1–35.
27.
FineN.DimitriouI.D.RulloJ.SandiM.J.PetriB.HaitsmaJ.IbrahimH.La RoseJ.GlogauerM.KubesP.CybulskyM. and RottapelR., GEF-H1 is necessary for neutrophil shear stress-induced migration during inflammation, The Journal of Cell Biology215 (2016), 107–119. doi:10.1083/jcb.201603109.
28.
RiehlB.D.LeeJ.S.HaL. and LimJ.Y., Fluid-flow-induced mesenchymal stem cell migration: Role of focal adhesion kinase and RhoA kinase sensors, Journal of the Royal Society, Interface12 (2015).
29.
YuanL.SakamotoN.SongG. and SatoM., Migration of human mesenchymal stem cells under low shear stress mediated by mitogen-activated protein kinase signaling, Stem Cells Dev21 (2012), 2520–2530. doi:10.1089/scd.2012.0010.
30.
YuanL.SakamotoN.SongG. and SatoM., Low-level shear stress induces human mesenchymal stem cell migration through the SDF-1/CXCR4 axis via MAPK signaling pathways, Stem Cells Dev22 (2013), 2384–2393. doi:10.1089/scd.2012.0717.
31.
MalekA.M.AlperS.L. and IzumoS., Hemodynamic shear stress and its role in atherosclerosis, Jama282 (1999), 2035–2042. doi:10.1001/jama.282.21.2035.
32.
LimK.T.HexiuJ.KimJ.SeonwooH.ChoungP.H. and ChungJ.H., Synergistic effects of orbital shear stress on in vitro growth and osteogenic differentiation of human alveolar bone-derived mesenchymal stem cells, BioMed Research International2014 (2014), 316803.
33.
HuangY.JiaX.BaiK.GongX. and FanY., Effect of fluid shear stress on cardiomyogenic differentiation of rat bone marrow mesenchymal stem cells, Archives of Medical Research41 (2010), 497–505. doi:10.1016/j.arcmed.2010.10.002.
34.
RiddleR.C.TaylorA.F.GenetosD.C. and DonahueH.J., MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation, American Journal of Physiology. Cell Physiology290 (2006), 776–784. doi:10.1152/ajpcell.00082.2005.
35.
BradyR.T.O’BrienF.J. and HoeyD.A., Mechanically stimulated bone cells secrete paracrine factors that regulate osteoprogenitor recruitment, proliferation, and differentiation, Biochemical and Biophysical Research Communications459 (2015), 118–123.
36.
WangG.ZhangQ.ZhuoZ.WuS.XuY.ZouL.GanL.TanK.XiaH.LiuZ. and GaoY., Enhanced homing of CXCR-4 modified bone marrow-derived mesenchymal stem cells to acute kidney injury tissues by micro-bubble-mediated ultrasound exposure, Ultrasound Med Biol42 (2016), 539–548. doi:10.1016/j.ultrasmedbio.2015.10.005.
37.
HwangS.J.SongY.M.ChoT.H.KimR.Y.LeeT.H.KimS.J.SeoY.K. and KimI.S., The implications of the response of human mesenchymal stromal cells in three-dimensional culture to electrical stimulation for tissue regeneration, Tissue Engineering. Part A18 (2012), 432–445. doi:10.1089/ten.tea.2010.0752.
38.
HonczarenkoM.LeY.SwierkowskiM.GhiranI.GlodekA.M. and SilbersteinL.E., Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors, Stem Cells24 (2006), 1030–1041. doi:10.1634/stemcells.2005-0319.
39.
SacksteinR.MerzabanJ.S.CainD.W.DagiaN.M.SpencerJ.A.LinC.P. and WohlgemuthR., Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone, Nature Medicine14 (2008), 181–187. doi:10.1038/nm1703.
40.
SegersV.F.Van RietI.AndriesL.J.LemmensK.DemolderM.J.De BeckerA.J.KockxM.M. and De KeulenaerG.W., Mesenchymal stem cell adhesion to cardiac microvascular endothelium: Activators and mechanisms, American Journal of Physiology. Heart and Circulatory Physiology290 (2006), 1370–1377. doi:10.1152/ajpheart.00523.2005.
41.
ChamberlainG.SmithH.RaingerG.E. and MiddletonJ., Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: Effects of chemokines and shear, PLoS One6 (2011), e25663. doi:10.1371/journal.pone.0025663.
42.
ThankamonyS.P. and SacksteinR., Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells, Proc Natl Acad Sci USA108 (2011), 2258–2263. doi:10.1073/pnas.1018064108.
43.
StrokaK.M. and Aranda-EspinozaH., A biophysical view of the interplay between mechanical forces and signaling pathways during transendothelial cell migration, The FEBS Journal277 (2010), 1145–1158. doi:10.1111/j.1742-4658.2009.07545.x.
44.
StrokaK.M. and Aranda-EspinozaH., Neutrophils display biphasic relationship between migration and substrate stiffness, Cell Motility and the Cytoskeleton66 (2009), 328–341. doi:10.1002/cm.20363.
45.
TeoG.S.AnkrumJ.A.MartinelliR.BoettoS.E.SimmsK.SciutoT.E.DvorakA.M.KarpJ.M. and CarmanC.V., Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-alpha-activated endothelial cells via both leukocyte-like and novel mechanisms, Stem Cells30 (2012), 2472–2486. doi:10.1002/stem.1198.
46.
BuronF.PerrinH.MalcusC.HequetO.ThaunatO.Kholopp-SardaM.N.MoulinF.T. and MorelonE., Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: An in vitro study using human cells, Transplantation Proceedings41 (2009), 3347–3352. doi:10.1016/j.transproceed.2009.08.030.
47.
DuijvesteinM.MolendijkI.RoelofsH.VosA.C.VerhaarA.P.ReindersM.E.FibbeW.E.VerspagetH.W.van den BrinkG.R.WildenbergM.E. and HommesD.W., Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease, Cytotherapy13 (2011), 1066–1073. doi:10.3109/14653249.2011.597379.
48.
HoogduijnM.J.CropM.J.KorevaarS.S.PeetersA.M.EijkenM.MaatL.P.BalkA.H.WeimarW. and BaanC.C., Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin, Transplantation86 (2008), 1283–1291. doi:10.1097/TP.0b013e31818aa536.
49.
NuzziR.GunettiM.RustichelliD.RoagnaB.Fronticelli BardelliF.FagioliF. and FerreroI., Effect of in vitro exposure of corticosteroid drugs, conventionally used in AMD treatment, on mesenchymal stem cells, Stem Cells Int2012 (2012), 946090.
50.
SchneiderN.Goncalves FdaC.PintoF.O.LopezP.L.AraujoA.B.PfaffensellerB.PassosE.P.Cirne-LimaE.O.MeurerL.LamersM.L. and PazA.H., Dexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behavior, PLoS One10 (2015), e0120538. doi:10.1371/journal.pone.0120538.
51.
FukudaS.MitsuokaH. and Schmid-SchonbeinG.W., Leukocyte fluid shear response in the presence of glucocorticoid, Journal of Leukocyte Biology75 (2004), 664–670. doi:10.1189/jlb.1003464.
52.
LiY.CharifN.MainardD.BensoussanD.StoltzJ.F. and de IslaN., Donor’s age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity, Biomed Mater Eng24 (2014), 47–52.
53.
LeBlancA.J. and HoyingJ.B., Adaptation of the coronary microcirculation in aging, Microcirculation23 (2016), 157–167. doi:10.1111/micc.12264.
54.
HarveyA.MontezanoA.C. and TouyzR.M., Vascular biology of ageing-implications in hypertension, Journal of Molecular and Cellular Cardiology83 (2015), 112–121. doi:10.1016/j.yjmcc.2015.04.011.
55.
HoeferI.E.den AdelB. and DaemenM.J., Biomechanical factors as triggers of vascular growth, Cardiovascular Research99 (2013), 276–283. doi:10.1093/cvr/cvt089.
